Biochemical and Genetic Markers in Liver DiseasesNCT01706614
Biochemical and Genetic Markers in Liver Diseases
An observational study of Biochemical and Genetic Markers in Liver Diseases, run by University Hospital Heidelberg at 1 site in Germany.
Trial summary
Investigation of biochemical and genetic markers in liver disease that might have an influence on the course of the disease Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Biochemical and Genetic Markers in Liver Diseases
- How many people
- 500 participants
- Where
- 1 siteGermany
- Study dates
- Apr 2012to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients with liver disease seen at department of Gastroenterology, University Hospital Heidelberg
Who may be able to join
- suffering from liver disease
- age of 18 years or older
- agreement to participate in study
Who cannot join
- younger than 18 years
- no consent to participate
Trial locations and contacts
1 site in 1 country.
Germany1 site, 1 recruiting
- Recruiting
University Hospital Heidelberg
Heidelberg, 69120
Karolin J Hoeh, 004962218702, karolin.hoeh@med.uni-heidelberg.de
Karolin J Hoeh
About this study
Investigation of biochemical and genetic markers in liver disease that might have an influence on the course of the disease
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2012 (estimated)
- Study startApr 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Biochemical and Genetic Markers in Liver DiseasesStudies of the same condition, open and under way.
- More trials run by University Hospital HeidelbergThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital Heidelberg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Karolin Hoeh, University Hospital Heidelberg
- Investigators
- Karolin J Hoeh, Principal investigator, University Hospital Heidelberg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01706614
- Sponsor's protocol ID
- S-565/2011
- Status last verified
- Oct 2012
- First submitted
- 10 Oct 2012
- Last updated
- 15 Oct 2012
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Biochemical and Genetic Markers in Liver Diseases
- ClinicalTrials.gov ID
- NCT01706614
- Acronym / sponsor ID
- S-565/2011
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- University Hospital HeidelbergUniversity, hospital or other
- Study start
- Apr 2012
- First posted
- 15 Oct 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation of biochemical and genetic markers in liver disease that might have an influence on the course of the disease
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients with liver disease seen at department of Gastroenterology, University Hospital Heidelberg
Key inclusion criteria (3 listed)
- suffering from liver disease
- age of 18 years or older
- agreement to participate in study
Key exclusion criteria (2 listed)
- younger than 18 years
- no consent to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2012.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Karolin J Hoeh principal investigator
University Hospital Heidelberg
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Biochemical and Genetic Markers in Liver Diseases, run by University Hospital Heidelberg at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Karolin J Hoeh (+49-6221-56-8702, karolin.hoeh@med.uni-heidelberg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2012.